SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001385508-18-000076
Filing Date
2018-09-20
Accepted
2018-09-20 16:20:07
Documents
4
Period of Report
2018-09-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K opiant_8-kseptemberx172018.htm 8-K 32765
2 EXHIBIT 10.86 bardaopiantcontract_ctrred.htm EX-10.86 724183
3 opiantpharmaceuticalsinc001.jpg GRAPHIC 146551
4 opiantpharmaceuticalsinc002.jpg GRAPHIC 61823
  Complete submission text file 0001385508-18-000076.txt   1045512
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38193 | Film No.: 181079668
SIC: 1000 Metal Mining